Patron Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-619
Closed -$222K – 170
2023
Q3
$222K Hold
619
– – 0.16% 144
2023
Q2
$235K Hold
619
– – 0.17% 139
2023
Q1
$297K Sell
619
-10
-2% -$4.68K 0.22% 125
2022
Q4
$264K Buy
629
+30
+5% +$12.1K 0.2% 125
2022
Q3
$250K Hold
599
– – 0.21% 126
2022
Q2
$297K Buy
599
+39
+7% +$20.3K 0.24% 118
2022
Q1
$315K Hold
560
– – 0.21% 124
2021
Q4
$423K Hold
560
– – 0.28% 100
2021
Q3
$417K Buy
560
+4
+0.7% +$3K 0.31% 95
2021
Q2
$358K Buy
556
+12
+2% +$7.3K 0.27% 109
2021
Q1
$310K Hold
544
– – 0.26% 109
2020
Q4
$317K Buy
+544
New +$310K 0.31% 91

Other funds holding BIO

Patron Partners's BIO Position: Q4 2023 in Review

Patron Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 619 shares — an estimated $222K sold.

Patron Partners first reported a position in BIO in Q4 2020 and held it in 12 quarters. The position peaked at $423K in Q4 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Patron Partners reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Patron Partners sold 619 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $222K.
  • Patron Partners first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and held it in 12 quarters.
  • Patron Partners's Bio-Rad Laboratories Class A position peaked at $423K in Q4 2021.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Patron Partners's 13F filing for Q4 2023, filed 18 Jan 2024.